StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies total assets

Total assets on the balance sheet at the end of each period.

BioStem Technologies's total assets was $48.82M at Jun 30, 2026. For fiscal 2025 it was $50.03M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$50.03M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$48.82M–
Q4 FY2025Dec 31, 2025$50.03M–

More BioStem Technologies figures

See a number that looks wrong?